ADAM17 Antikörper (C-Term)
Kurzübersicht für ADAM17 Antikörper (C-Term) (ABIN1030720)
Target
Alle ADAM17 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- 80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
-
-
-
Applikationshinweise
- TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
-
-
: "ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).
-
-
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
-
Andere Bezeichnung
- TACE
-
Molekulargewicht
- Predicted: 93 kDa
-
Pathways
- Notch Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Response to Growth Hormone Stimulus
Target
-